These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25944200)

  • 1. "Right to Try" Laws: The Gap between Experts and Advocates.
    Dresser R
    Hastings Cent Rep; 2015; 45(3):9-10. PubMed ID: 25944200
    [No Abstract]   [Full Text] [Related]  

  • 2. The strange allure of state "right-to-try" laws.
    Zettler PJ; Greely HT
    JAMA Intern Med; 2014 Dec; 174(12):1885-6. PubMed ID: 25264589
    [No Abstract]   [Full Text] [Related]  

  • 3. An audience with Tatiana Prowell. Interviewed by Asher Mullard.
    Prowell T
    Nat Rev Drug Discov; 2014 Jun; 13(6):410-1. PubMed ID: 24875091
    [No Abstract]   [Full Text] [Related]  

  • 4. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
    Ochs A
    Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
    [No Abstract]   [Full Text] [Related]  

  • 5. Demand grows for early access to promising cancer drugs.
    Baldwin J
    J Natl Cancer Inst; 2002 Nov; 94(22):1668-70. PubMed ID: 12441318
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right to try?
    Lieu CH; Sorkin A; Messersmith WA
    J Clin Oncol; 2015 May; 33(13):1518. PubMed ID: 25779561
    [No Abstract]   [Full Text] [Related]  

  • 8. The terminally ill, access to investigational drugs, and FDA rules.
    Blake V
    Virtual Mentor; 2013 Aug; 15(8):687-91. PubMed ID: 23937785
    [No Abstract]   [Full Text] [Related]  

  • 9. From a constitutional right to a policy of exceptions: Abigail Alliance and the future of access to experimental therapy.
    Shah S; Zettler P
    Yale J Health Policy Law Ethics; 2010; 10(1):135-96. PubMed ID: 20229846
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigational drug access taken to task in lawsuit against FDA.
    Randal J
    J Natl Cancer Inst; 2003 Dec; 95(24):1818-20. PubMed ID: 14679146
    [No Abstract]   [Full Text] [Related]  

  • 11. No way to save a life: allowing terminally ill patients access to drugs that have not completed clinical trials is a dangerous move.
    Moss RW
    New Sci; 2006 Jun 3-9; 190(2554):21. PubMed ID: 16832956
    [No Abstract]   [Full Text] [Related]  

  • 12. The proper focus for FDA regulations: why the fundamental right to self-preservation should allow terminally ill patients with no treatment options to attempt to save their lives.
    Puckett A
    SMU Law Rev; 2007; 60(2):635-65. PubMed ID: 17849632
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient group seeks overhaul of FDA clinical trial system in court.
    Hede K
    J Natl Cancer Inst; 2006 Sep; 98(18):1268-70. PubMed ID: 16985242
    [No Abstract]   [Full Text] [Related]  

  • 14. [Off-label use in oncology. The Italian choice].
    Felicetti V; Gremigni U; Cifaldi L
    Recenti Prog Med; 2008 Dec; 99(12):612-5. PubMed ID: 19388222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer drugs. Weighing the risks and benefits.
    Bren L
    FDA Consum; 2007; 41(1):10-9. PubMed ID: 17342832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical, legal, and ethical issues in expanded access to investigational drugs.
    Darrow JJ; Sarpatwari A; Avorn J; Kesselheim AS
    N Engl J Med; 2015 Jan; 372(3):279-86. PubMed ID: 25587952
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Demand grows for early access to promising cancer drugs.
    Genève J
    J Natl Cancer Inst; 2003 Mar; 95(6):492. PubMed ID: 12644549
    [No Abstract]   [Full Text] [Related]  

  • 18. Neoadjuvant trials could speed up drug approvals.
    Peres J
    J Natl Cancer Inst; 2014 Mar; 106(3):dju072. PubMed ID: 24610911
    [No Abstract]   [Full Text] [Related]  

  • 19. Patient advocacy. 'Right to Try' laws bypass FDA for last-ditch treatments.
    Servick K
    Science; 2014 Jun; 344(6190):1329. PubMed ID: 24948714
    [No Abstract]   [Full Text] [Related]  

  • 20. Food and Drug Administration responds to pressure for expanded drug access.
    Brower V
    J Natl Cancer Inst; 2014 Jun; 106(6):dju171. PubMed ID: 24907387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.